Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dalcetrapib
dalcetrapib
Canadians hope $250 mln trial can revive failed Roche heart drug
Yahoo/Reuters
Tue, 06/9/15 - 11:59 am
Canada
Roche
drug trials
DalCor Pharmaceuticals
dalcetrapib
Roche’s Good Cholesterol Drug Shows Negative Side Effects
Bloomberg
Mon, 11/5/12 - 04:59 pm
Roche
dalcetrapib
CETP inhibitors
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Roche
Merck
dalcetrapib
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Eli Lilly
Pfizer
Sanofi
Illumina
Roche Drops After Halting Cholesterol Drug Development
Bloomberg
Mon, 05/7/12 - 10:58 am
Roche
dalcetrapib
Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About
Seeking Alpha
Sun, 11/20/11 - 12:14 pm
CETP inhibitors
Merck
Roche
Eli Lilly
Anacetrapib
dalcetrapib
evacetrapib
Roche expects $10 billion sales for HDL drug
Yahoo/Reuters
Mon, 09/26/11 - 11:31 am
Roche
HDL therapy
Merck
dalcetrapib
Anacetrapib
Roche Rises After Good-Cholesterol Drug Shows Promise in Study
Bloomberg
Mon, 08/22/11 - 10:33 am
Roche
dalcetrapib
Roche Seeks Win on Heart Pill Where Pfizer Failed
Bloomberg
Fri, 08/19/11 - 09:07 am
Roche
Pfizer
dalcetrapib
heart disease